GlassScriptPhysician profile
Haritha Pavuluri
NPI 1457939241
$4,028.04
in general payments reported to CMS, 2019-2025
17 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $367 · 2023: $917 · 2024: $1,664 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,807 · Travel and Lodging: $655 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,806.81 |
| Travel and Lodging | $654.56 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,773.76 | 2022-2025 | Ams 700, Lithovue, Naviguide |
| Olympus Corporation of The Americas | $678.50 | 2024 | Cysto-Nephro Videoscope, Visiglide |
| Coloplast Corp | $412.23 | 2023-2025 | Titan, Altis, Speedicath |
| Astellas Pharma US INC | $247.22 | 2023-2024 | Xtandi |
| Urogen Pharma, INC. | $228.70 | 2025 | |
| Antares Pharma, INC. | $122.85 | 2022 | |
| Progenics Pharmaceuticals, INC. | $87.45 | 2023 | Pylarify |
| Innovation Technologies INC | $79.50 | 2022 | |
| Janssen Biotech, INC. | $64.67 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $57.40 | 2024-2025 | Adstiladrin |
| Photocure INC | $53.43 | 2024-2025 | Cysview |
| Olympus America INC. | $52.50 | 2024 | Itind System |
| Sumitomo Pharma America, INC. | $50.62 | 2025 | Gemtesa |
| Teleflex LLC | $48.44 | 2025 | Urolift |
| Bluewind Medical | $28.33 | 2024 | Revi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.54 | 2022 | |
| Pfizer INC. | $19.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Pavuluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.